Stay updated on Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma
Sign up to get notified when there's something new on the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page.

Latest updates to the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedFooter now shows Revision: v3.3.3. The HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 entry were removed.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe History page now shows a new revision entry (v3.3.2) and the older revision (v3.2.0) has been removed. This update affects only the revision log and does not alter study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange Detected- Removed the notice about lapse in government funding and operating status from the page.SummaryDifference0.6%

- Check59 days agoChange DetectedOnly minor visual/layout adjustments were observed on the Record History page; no substantive content changes were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check87 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference11%

- Check94 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.3%

Stay in the know with updates to Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page.